![IceCure ProSense DMS-7063 User Manual Download Page 129](http://html1.mh-extra.com/html/icecure/prosense-dms-7063/prosense-dms-7063_user-manual_3378524129.webp)
IceCure™ Medical Ltd.
DMS-7063 rev. C
ProSense™
Confidential
User Manual
129
US User Manual
microwave coagulation therapy: an underestimated tool in the toolbox., Ann Surg Oncol.
2015 Apr;22(4):1294-300. Epub 2014 Oct 7., Ann Surg Oncol. 2015
33.
Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, Bai W, Dong Z, Lu Y, Zeng Z, Lou M, Wang
H, Gao X, Chang X, An L, Qu J, Li J, Yang Y., Multicenter randomized controlled trial of
percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma.,
Hepatology. 2015 May;61(5):1579-90. Epub 2015 Mar 20., Hepatology. 2015
34.
Rong, G., Bai, W., Dong, Z., Wang, C., Lu, Y., Zeng, Z., . . . Yang, Y. (2014). Cryotherapy for
cirrhosis-based hepatocellular carcinoma: A single center experience from 1595 treated
cases. Frontiers of Medicine, 9(1), 63-71.
35.
Rong, G., Bai, W., Dong, Z., Wang, C., Lu, Y., Zeng, Z., . . . Yang, Y. (2015). Long-Term
Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma
within Milan Criteria. Plos One, 10(4).
36.
Littrup, P. J., Aoun, H. D., Adam, B., Krycia, M., Prus, M., & Shields, A. (2016).
Percutaneous cryoablation of hepatic tumors: Long-term experience of a large U.S. series.
Abdominal Radiology, 41(4), 767-780.
37.
Callstrom, M. R., & Kurup, A. N. (n.d.). Percutaneous ablation of painful metastases
involving bone. Interventional
a.
Oncology, 243-254.
38.
-Rosenthal, D., & Callstrom, M. R. (2012). Critical Review and State of the Art in
Interventional Oncology: Benign and Metastatic Disease Involving Bone. Radiology,
262(3), 765-780.
39.
Coupal TM, Mallinson PI, Munk PL, Liu D, Clarkson P, Ouellette H., CT-guided
percutaneous cryoablation for osteoid osteoma: initial experience in adults., AJR Am J
Roentgenol. 2014 May;202(5):1136-9., AJR Am J Roentgenol. 2014
40.
Baust, J. G., Bischof, J. C., Jiang-Hughes, S., Polascik, T. J., Rukstalis, D. B., Gage, A. A., &
Baust, J. M. (2015). Re-
purposing cryoablation: A combinatorial ‘therapy’ for the
destruction of tissue. Prostate Cancer and Prostatic Diseases, 18(2), 87-95.
41.
Woolley, M. L., Schulsinger, D. A., Durand, D. B., Zeltser, I. S., & Waltzer, W. C. (2002).
Effect of Freezing Parameters (Freeze Cycle and Thaw Process) on Tissue Destruction
Following Renal Cryoablation. Journal of Endourology, 16(7), 519-522.
42.
McArthur HL, Diab A, Page DB, Yuan J, Solomon SB, Sacchini V, Comstock C, Durack JC,
Maybody M, Sung J, Ginsberg A, Wong P, Barlas A, Dong Z, Zhao C, Blum B, Patil S, Neville
D, Comen E, Morris EA, Kotin A, Brogi E, et al. A pilot study of preoperative single-dose
ipilimumab and/or cryoablation in women with early-stage breast cancer with
comprehensive immune profiling. Clin Cancer Res. 2016 Aug 26. Epub ahead of print Clin
Cancer Res. 2016
43.
Chu, K. F., & Dupuy, D. E. (2014). Thermal ablation of tumours: Biological mechanisms and
advances in therapy. Nature Reviews Cancer, 14(3), 199-208.
44.
Sabel, M. S. (2009). Cryo-immunology: A review of the literature and proposed
mechanisms for stimulatory versus suppressive immune responses. Cryobiology, 58(1), 1-
11.